The extrinsic apoptosis pathway and its prognostic impact in ovarian cancer

Evelien W Duiker1, Ate G J van der Zee, Pauline de Graeff

  • 1Department of Medical Oncology, University Medical Center Groningen and University of Groningen, Groningen, The Netherlands.

Gynecologic Oncology
|December 5, 2009
PubMed
Abstract

Insights

Loss of Fas and TRAIL expression in ovarian cancer correlates with poorer prognosis and dedifferentiation. While most tumors express DR4, DR5, caspase 8, and c-FLIP, only Fas and TRAIL levels impact survival, suggesting targeted therapies should consider c-FLIP levels.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Death ligands (FasL, TRAIL) and their receptors (Fas, DR4, DR5) are implicated in cancer development, immune surveillance, and chemotherapy response.
  • Tumor necrosis factor related apoptosis inducing ligand (TRAIL) receptor agonists are under investigation as anti-cancer therapeutics.
  • Caspase 8 and its inhibitor c-FLIP play crucial roles in apoptosis signaling pathways relevant to cancer.

Purpose of the Study:

  • To investigate the correlation between the expression of death pathway components (Fas, FasL, TRAIL, DR4, DR5, caspase 8, c-FLIP) in ovarian cancers.
  • To determine the relationship between these molecular markers and patient response to chemotherapy.
  • To assess the association of these markers with overall survival and progression-free survival in ovarian cancer patients.

Main Methods:

  • Immunohistochemistry was employed to quantify the expression of Fas, FasL, TRAIL, DR4, DR5, caspase 8, and c-FLIP.
  • Protein expression levels were analyzed on a tissue microarray comprising 382 ovarian cancer samples.
  • Statistical correlations were performed between marker expression, clinicopathologic variables, chemotherapy response, and survival outcomes.

Main Results:

  • High expression of c-FLIP was frequently observed and associated with caspase 8 and TRAIL receptor expression.
  • Loss of TRAIL expression correlated with lower tumor grade and improved progression-free survival (HR 0.63).
  • Loss of Fas expression was linked to better progression-free survival (HR 0.54) and disease-specific survival (HR 0.49), and associated with lower tumor grade.

Conclusions:

  • Reduced expression of Fas and TRAIL in ovarian cancers is linked to dedifferentiation and a poorer prognosis.
  • Widespread expression of DR4, DR5, caspase 8, and c-FLIP in ovarian cancers did not show a direct correlation with patient survival.
  • The expression level of c-FLIP should be considered when developing targeted therapies aimed at death receptors in ovarian cancer treatment.

Related Concept Videos

The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.